273 related articles for article (PubMed ID: 23627940)
21. Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.
Li X; Xu Q; Li C; Luo J; Li X; Wang L; Jiang B; Shi D
Eur J Med Chem; 2019 Mar; 166():178-185. PubMed ID: 30711829
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of protein tyrosine phosphatase 1B by flavonoids: A structure - activity relationship study.
Proença C; Freitas M; Ribeiro D; Sousa JLC; Carvalho F; Silva AMS; Fernandes PA; Fernandes E
Food Chem Toxicol; 2018 Jan; 111():474-481. PubMed ID: 29175190
[TBL] [Abstract][Full Text] [Related]
23. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
[TBL] [Abstract][Full Text] [Related]
24. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders.
Singh S; Singh Grewal A; Grover R; Sharma N; Chopra B; Kumar Dhingra A; Arora S; Redhu S; Lather V
Bioorg Chem; 2022 Apr; 121():105626. PubMed ID: 35255350
[TBL] [Abstract][Full Text] [Related]
25. Protein tyrosine phosphatase 1B in metabolic diseases and drug development.
Delibegović M; Dall'Angelo S; Dekeryte R
Nat Rev Endocrinol; 2024 Jun; 20(6):366-378. PubMed ID: 38519567
[TBL] [Abstract][Full Text] [Related]
26. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
[No Abstract] [Full Text] [Related]
27. Anti-obesity and hypolipidemic effects of Rheum undulatum in high-fat diet-fed C57BL/6 mice through protein tyrosine phosphatase 1B inhibition.
Lee W; Yoon G; Hwang YR; Kim YK; Kim SN
BMB Rep; 2012 Mar; 45(3):141-6. PubMed ID: 22449699
[TBL] [Abstract][Full Text] [Related]
28. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
Liu G; Trevillyan JM
Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
[TBL] [Abstract][Full Text] [Related]
29. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
Zhang ZY; Lee SY
Expert Opin Investig Drugs; 2003 Feb; 12(2):223-33. PubMed ID: 12556216
[TBL] [Abstract][Full Text] [Related]
30. Varic acid analogues from fungus as PTP1B inhibitors: Biological evaluation and structure-activity relationships.
Sun W; Zhuang C; Li X; Zhang B; Lu X; Zheng Z; Dong Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3382-3385. PubMed ID: 28642102
[TBL] [Abstract][Full Text] [Related]
31. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
Harley EA; Levens N
Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209
[TBL] [Abstract][Full Text] [Related]
32. Role of protein tyrosine phosphatase 1B in cardiovascular diseases.
Thiebaut PA; Besnier M; Gomez E; Richard V
J Mol Cell Cardiol; 2016 Dec; 101():50-57. PubMed ID: 27596049
[TBL] [Abstract][Full Text] [Related]
33. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review.
Verma M; Gupta SJ; Chaudhary A; Garg VK
Bioorg Chem; 2017 Feb; 70():267-283. PubMed ID: 28043717
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents.
Onoda T; Li W; Higai K; Koike K
BMC Complement Altern Med; 2014 Feb; 14():64. PubMed ID: 24555682
[TBL] [Abstract][Full Text] [Related]
35. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications.
Teimouri M; Hosseini H; ArabSadeghabadi Z; Babaei-Khorzoughi R; Gorgani-Firuzjaee S; Meshkani R
J Physiol Biochem; 2022 May; 78(2):307-322. PubMed ID: 34988903
[TBL] [Abstract][Full Text] [Related]
36. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.
Kasibhatla B; Wos J; Peters KG
Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056
[TBL] [Abstract][Full Text] [Related]
37. Protein-tyrosine phosphatase 1B substrates and metabolic regulation.
Bakke J; Haj FG
Semin Cell Dev Biol; 2015 Jan; 37():58-65. PubMed ID: 25263014
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
He HB; Gao LX; Deng QF; Ma WP; Tang CL; Qiu WW; Tang J; Li JY; Li J; Yang F
Bioorg Med Chem Lett; 2012 Dec; 22(23):7237-42. PubMed ID: 23067554
[TBL] [Abstract][Full Text] [Related]
39. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
Liu P; Du Y; Song L; Shen J; Li Q
Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
[TBL] [Abstract][Full Text] [Related]
40. Endoplasmic reticulum stress and the on site function of resident PTP1B.
Popov D
Biochem Biophys Res Commun; 2012 Jun; 422(4):535-8. PubMed ID: 22609202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
